BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2050241)

  • 1. Pseudohomozygous type II hyperlipoproteinemia.
    Fujita M; Okamoto S; Shirai K; Saito Y; Yoshida S
    Dermatologica; 1991; 182(2):94-7. PubMed ID: 2050241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
    Aljenedil S; Ruel I; Watters K; Genest J
    J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sitosterolemia Presenting as Pseudohomozygous Familial Hypercholesterolemia.
    Renner C; Connor WE; Steiner RD
    Clin Med Res; 2016 Jun; 14(2):103-8. PubMed ID: 27231115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia.
    Katzmann J; Schürfeld C; März W; Laufs U
    J Clin Lipidol; 2018; 12(4):868-871. PubMed ID: 29866529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor.
    Komuro I; Kato H; Nakagawa T; Takahashi K; Mimori A; Takeuchi F; Nishida Y; Miyamoto T
    Am J Med Sci; 1987 Nov; 294(5):341-5. PubMed ID: 3425583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia.
    Coetzee GA; van der Westhuyzen DR; Berger GM; Henderson HE; Gevers W
    Arteriosclerosis; 1982; 2(4):303-11. PubMed ID: 6287984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia. Evidence for a newly recognized mutation determining increased fibroblast receptor affinity but decreased capacity for low density lipoprotein in two siblings.
    Ostlund RE; Levy RA; Witztum JL; Schonfeld G
    J Clin Invest; 1982 Oct; 70(4):823-31. PubMed ID: 6288770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
    Schmidt HH; Stuhrmann M; Shamburek R; Schewe CK; Ebhardt M; Zech LA; Büttner C; Wendt M; Beisiegel U; Brewer HB; Manns MP
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2167-74. PubMed ID: 9626156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Edge SB; Demosky SJ; Starzl TE; Triche T; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1986 May; 876(3):646-57. PubMed ID: 3707989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.
    Miyake Y; Tajima S; Yamamura T; Yamamoto A
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5151-5. PubMed ID: 6272292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary hypercholesterolemia].
    Kajinami K; Mabuchi H
    Nihon Rinsho; 1990 Nov; 48(11):2532-9. PubMed ID: 2270017
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracellular cholesterol accumulation and coenzyme Q
    Suárez-Rivero JM; de la Mata M; Pavón AD; Villanueva-Paz M; Povea-Cabello S; Cotán D; Álvarez-Córdoba M; Villalón-García I; Ybot-González P; Salas JJ; Muñiz O; Cordero MD; Sánchez-Alcázar JA
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3697-3713. PubMed ID: 30292637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia.
    Bilheimer DW
    Beitr Infusionsther; 1988; 23():61-73. PubMed ID: 2484783
    [No Abstract]   [Full Text] [Related]  

  • 15. Homozygous familial hypercholesterolemic patients in China.
    Cai HJ; Fan LM; Huang MG; Chen XY; Liu GQ; Chen Q
    Atherosclerosis; 1985 Nov; 57(2-3):303-12. PubMed ID: 4084360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinheritance of two mild defects in low density lipoprotein receptor function produces severe hypercholesterolemia.
    Uauy R; Vega GL; Grundy SM
    J Clin Endocrinol Metab; 1991 Jan; 72(1):179-87. PubMed ID: 1986017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese sisters associated with pseudohomozygous familial hypercholesterolemia and sitosterolemia.
    Yoshida A; Naito M; Miyazaki K
    J Atheroscler Thromb; 2000; 7(1):33-8. PubMed ID: 11425042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor deficiency resulting in familial hypercholesterolaemia in a black man. A follow-up study.
    Coetzee GA; van Wingerden JJ; van der Westhuyzen DR
    S Afr Med J; 1985 Feb; 67(7):259-61. PubMed ID: 3983774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: response to liver transplantation.
    Moyle M; Tate B
    Australas J Dermatol; 2004 Nov; 45(4):226-8. PubMed ID: 15527434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.